文献速递青光眼

开放角青光眼药物干预随机对照试验中被错失的机会

Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma.
PubMed 文献 · Br J Ophthalmol · 2017-03-07

该研究系统评价了401项开放角青光眼药物干预随机对照试验(截至2014年3月,共纳入76861名参与者),评估眼压和视野作为结局指标的报告情况。结果显示80%的试验提供了眼压的完整信息,仅11%的试验提供了视野的完整信息,仅少数试验随访患者至少1年,约半数报告声明接受工业界资助。作者认为视野数据不足是错失证据合成的机会。

要点

  • 401项试验中80%提供了眼压的完整信息,仅11%提供了视野的完整信息。
  • 仅少数试验随访患者至少1年。
  • 约半数报告声明接受工业界资助。

核心结论

  • 绝大多数试验提供了足够数据用于眼压的荟萃分析,但较少提供视野数据分析数据,作者认为这是错失的机会。
  • 研究者有义务为患者和提供者确定青光眼干预在患者重要结局方面的比较效果,不应浪费试验中本可收集的数据。

研究设计与样本

  • 对研究组开展的系统评价中已发表的药物干预开放角青光眼随机对照试验报告进行识别与评估。
  • 截至2014年3月,共识别401项试验,纳入76861名参与者。
  • 评估眼压和视野是否作为试验结局报告,并分类为可完全或不可完全用于荟萃分析。
  • 收集患者随访时长和试验资助来源数据。

主要发现

  • 401项试验中80%提供了眼压的完整信息,11%提供了视野的完整信息。
  • 仅少数试验随访患者至少1年。
  • 约半数报告声明接受工业界资助。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the extent to which intraocular pressure and visual field have been reported as outcomes in randomised controlled trials (also referred to as 'trials') of medical treatments for open-angle glaucoma. METHODS: We identified published reports of trials in a systematic review of medical interventions for open-angle glaucoma our group conducted. We assessed whether intraocular pressure and visual field were reported as trial outcomes and classified them to be either completely or incompletely reported for meta-analysis. We also collected data on the length of time patients were followed and source of funding for the trial. RESULTS: As of March 2014, we identified 401 trials that had enrolled 76 861 participants. Eighty per cent of 401 trials provided complete information on intraocular pressure and 11% of the 401 trials provided complete information on visual field. Only a minority of trials followed patients for at least 1 year. About half of all reports in our study stated that receiving funding from the industry. CONCLUSIONS: Although the vast majority of trials provided sufficient data for meta-analysis of the effect of medical management of open-angle glaucoma on intraocular pressure, relatively few provided data for analysing the effect on visual field. We considered this as missed opportunity because the data were not available for evidence synthesis. Investigators have an obligation to patients and providers to determine the comparative effectiveness of glaucoma interventions in terms of patient-important outcomes and not to waste data that could have been collected in trials.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Law A, Lindsley K, Rouse B, et al. Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma. Br J Ophthalmol. 2017. PMID: 28270487. doi:10.1136/bjophthalmol-2016-309695

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。